Literature DB >> 2837489

Quantitation of the guanine nucleotide binding regulatory protein Gs in S49 cell membranes using antipeptide antibodies to alpha s.

L A Ransnäs1, P A Insel.   

Abstract

Polyclonal antibodies reactive against the guanine nucleotide binding stimulatory protein, Gs, were affinity-purified from two rabbits immunized with a synthetic peptide corresponding to amino acids 28-42 in the alpha-subunit, alpha s. On immunoblots, these antibodies recognized alpha s, but not alpha-subunits from two other guanine nucleotide binding regulatory proteins, Gi and Go. A competitive enzyme-linked immunosorbent assay was developed in which inhibition of antibody binding to peptide-coated microtiter plates was used to quantitate purified Gs or Gs in cholate extracts of cell membranes. Plasma membranes derived from wild type S49 lymphoma cells contained 18.9 +/- 2.3 pmol/mg of membrane protein of alpha s. The same membranes bound 169 +/- 12 fmol/mg of protein of [125I]iodocyanopindolol to beta-adrenergic receptors, indicating that the amount of Gs is far in excess of the amount of beta-adrenergic receptors. Thus, even if every beta-adrenergic receptor molecule were to activate 10 Gs molecules, in order for Gs to be limiting for the receptors to reach their high affinity state, it is likely that compartmentation exists for target cell membrane receptors and Gs. Moreover, a comparison of beta-adrenergic receptor number and Gs levels in several different S49 lymphoma cell mutants having lesions in receptors or Gs argues against a coordinate regulation of beta-adrenergic receptors and Gs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2837489

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Inhibition of subunit dissociation and release of the stimulatory G-protein, Gs, by beta gamma-subunits and somatostatin in S49 lymphoma cell membranes.

Authors:  L A Ransnäs; D Leiber; P A Insel
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

Review 2.  The role of G-proteins in transduction of the beta-adrenergic response in heart failure.

Authors:  L A Ransnäs
Journal:  Heart Vessels Suppl       Date:  1991

3.  Functional coupling of the human dopamine D2 receptor with G alpha i1, G alpha i2, G alpha i3 and G alpha o G proteins: evidence for agonist regulation of G protein selectivity.

Authors:  Lucien Gazi; Sarah A Nickolls; Philip G Strange
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

Review 4.  Coupling mode of receptors and G proteins.

Authors:  Peter Hein; Moritz Bünemann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-12-02       Impact factor: 3.000

5.  Ontogeny of guanine-nucleotide-binding regulatory proteins in rabbit liver.

Authors:  Y Kawai; I J Arinze
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

6.  Expression of the Gs protein alpha-subunit disrupts the normal program of differentiation in cultured murine myogenic cells.

Authors:  C C Tsai; J E Saffitz; J J Billadello
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

7.  Stimulation of beta-adrenergic receptors of S49 lymphoma cells redistributes the alpha subunit of the stimulatory G protein between cytosol and membranes.

Authors:  L A Ransnäs; P Svoboda; J R Jasper; P A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

8.  Noncoordinate regulation of cardiac Gs protein and beta-adrenergic receptors by a physiological stimulus, chronic dynamic exercise.

Authors:  H K Hammond; L A Ransnas; P A Insel
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

9.  Fluoride interaction with G-proteins.

Authors:  J M Stadel; S T Crooke
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

10.  Chronic norepinephrine elicits desensitization by uncoupling the beta-receptor.

Authors:  D E Vatner; S F Vatner; J Nejima; N Uemura; E E Susanni; T H Hintze; C J Homcy
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.